Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Organizing biological data
Effect of ATRA on HH, Hut78 and NB4 cells
Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development
Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [RNA-seq 2]
Palbociclib synergizes with ATRA to induce differentiation in AML
Combination of triciribine and p38 inhibitors enhances the differentiation effect on myeloid leukemia cells
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments (Cell Lines)
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments (Xenografts)
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments
Effects of fucosylation inhibitors on ATRA differentiation in myeloid leukemia cells
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [CUT&TAG]
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia [RNA-seq]
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia
Gene expression profiling of ATRA-resistant NB4-MR4 subclone (R4 cell line) treated with a CHK1 inhibitor i(MK-8776).
Treatment with HKMTI-1-005, a dual inhibitor of EZH2 and G9a/GLP histone methyltransferases, promotes differentiation of acute myeloid leukaemialeukemia
Human bone marrow transcriptome sequencing
miRNAs screening in small extracellular vesicles (sEVs) from patients with primary antiphospholipid syndrome (PAPS)
Sphingobacterium sp. UT-1RO-CII-1
Sphingobacterium sp. UT-1RO-CII-1 Genome sequencing and assembly
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML-RARA in Acute Promyelocytic Leukemia [APL PBMCs ATAC-seq]
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML-RARA in Acute Promyelocytic Leukemia [Cut&Tag]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on